R. M. Sari

Six-month follow up of a randomized clinical trial-phase I study in Indonesian adults and children: Safety and immunogenicity of Salmonella typhi polysaccharide-diphtheria toxoid (Vi-DT) conjugate vaccine

J. Yang, J. Excler, I. Rengganis, 2019, PloS one.

A novel Vi-diphtheria toxoid typhoid conjugate vaccine is safe and can induce immunogenicity in healthy Indonesian children 2–11 years: a phase II preliminary report

J. Yang, S. Hadinegoro, H. I. Satari, 2020, BMC Pediatrics.

One-month follow up of a randomized clinical trial-phase II study in 6-<24 months old Indonesian subjects: Safety and immunogenicity of Vi-DT Typhoid Conjugate Vaccine.

J. Yang, S. Hadinegoro, H. I. Satari, 2020, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Safety and immunogenicity of human neonatal RV3 rotavirus vaccine (Bio Farma) in adults, children, and neonates in Indonesia: Phase I Trial.

J. Bines, Y. Soenarto, Rini Mulia Sari, 2021, Vaccine.

Immunogenicity of four doses of oral poliovirus vaccine when co-administered with the human neonatal rotavirus vaccine (RV3-BB)

Katherine J. Lee, J. Bines, D. Cowley, 2019, Vaccine.

Comparison of Immunogenicity and Safety of Diphtheria–Tetanus–Pertussis–Hepatitis B–Haemophilus influenza B (Bio Farma) with Pentabio® Vaccine Primed with Recombinant Hepatitis B at Birth (Using Different Source of Hepatitis B) in Indonesian Infants

C. Kartasasmita, E. Fadlyana, K. Rusmil, 2023, Vaccines.

The quantity and quality of anti-PRP induced by the new Indonesian DTwP-HB-Hib vaccine compared to the Hib vaccine given with the DTwP-HB vaccine

C. Kartasasmita, K. Rusmil, H. Sukandar, 2018 .

The immunogenicity, safety, and consistency of an Indonesia combined DTP-HB-Hib vaccine in expanded program on immunization schedule

E. Fadlyana, K. Rusmil, S. Hadinegoro, 2015, BMC Pediatrics.

Immunogenicity and safety of Quadrivalent Influenza HA vaccine in Indonesian children: An open-labeled, bridging, clinical study.

C. Kartasasmita, E. Fadlyana, K. Rusmil, 2019, Vaccine.

Immunogenicity and safety of a Trivalent Influenza HA vaccine in Indonesian infants and children.

S. Hadinegoro, H. I. Satari, R. Sekartini, 2018, Vaccine.

A phase III, observer-blind, randomized, placebo-controlled study of the efficacy, safety, and immunogenicity of SARS-CoV-2 inactivated vaccine in healthy adults aged 18–59 years: An interim analysis in Indonesia

C. Kartasasmita, E. Fadlyana, K. Rusmil, 2021, Vaccine.